Drug intelligence / Profile preview

(2-amino-1,3-oxazol-5-yl)-(3-bromophenyl)methanone

Development stage: Unknown
Modality: Small Molecules

Overview

(2-Amino-1,3-oxazol-5-yl)-(3-bromophenyl)methanone is a small molecule with the molecular formula C10H7BrN2O2 and a molecular weight of approximately 267.08 g/mol. It features an oxazole ring substituted at the 5-position with a (3-bromobenzoyl) group and at the 2-position with an amino group. There is no publicly available information regarding its mechanism of action or clinical development status in major databases such as PubChem or ChemSpider[1][2]. The compound appears to be primarily used in research settings.

Other names: (2-Amino-1,3-Oxazol-5-Yl)-(3-Bromophenyl)methanone5-(3-bromobenzoyl)-1,3-oxazol-2-amineamino-oxazole, 2SCHEMBL5213541[1][2]

Targets

ACC (Acetyl-CoA Carboxylase 1)

Beyond the preview

Go deeper on (2-amino-1,3-oxazol-5-yl)-(3-bromophenyl)methanone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on (2-amino-1,3-oxazol-5-yl)-(3-bromophenyl)methanone.

Explore the full profile